Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Docusate Sodium Capsules (USP, RX Only) Supplier

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract opportunity is for the supply of pharmaceutical-grade Docusate Sodium Capsules to support prime contractors on DLA Troop Support Medical Supply Chain Pharm FSA projects. The selected supplier must manufacture or source 10 mg unit dose capsules that meet USP standards and RX Only compliance, ensuring a minimum shelf life of 36 months. The contract requires the delivery of 1,000 packages, with each package containing 100 capsules. To be eligible, suppliers must utilize FDA-approved manufacturing facilities and strictly adhere to the Buy American Act and the Berry Amendment. The performance of this contract is centered at Fort Campbell, Kentucky. Interested parties should note the response deadline of October 28, 2026, for this Department of Defense requirement under NAICS code 325412.

General Info

Supply 100,000 USP Docusate Sodium Capsules for DLA at Fort Campbell by 2026.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

FORT CAMPBELL, KY, 42223-5000, USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2DP-27-T-0146.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

DOCUSATE SODIUM CAPSUL

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supplies Docusate Sodium Capsules for prime contractors on DLA Troop Support Medical Supply Chain Pharm FSA projects. Manufactures or sources pharmaceutical-grade capsules meeting USP standards and RX Only compliance. Requires FDA-approved manufacturing facilities and adherence to the Buy American Act and Berry Amendment. Delivers 1.000 package of 100 unit dose (10 mg) capsules with a 36-month shelf life.

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
Federal
6505--Sacubitril/Valsartan Tablets (VA-27-00014055)
Solicitation # 36E79727R0007
The Department of Veterans Affairs Enterprise Procurement Office intends to award a single, unrestricted national mandatory requirements contract for an uninterrupted source of supply of Sacubitril-Valsartan Tablets. This procurement, issued under NAICS code 325412 and FAR Part 12, supports multiple federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will span a one-year base period with four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, requiring the contractor to execute necessary chargeback agreements to ensure timely delivery. The successful offeror must provide a unique eleven-digit National Drug Code (NDC) where the first five digits identify the offeror, and this must be the only label on the product. Strict packaging specifications are required for 60 and 180 count bottles, including a minimum volume of 120cc, a cylindrical body with at least a 5.75 inch circumference, and a safety cap that is either convertible or deshellable. Bottles must accommodate a 5.25 by 2 inch label with an additional 0.5 inch of space for barcodes and expiration data. Offerors who are not the manufacturer must provide a letter of commitment ensuring a sufficient source of supply. The solicitation is expected to be issued around December 18, 2026, with a tentative closing date of January 7, 2027.
Nac Pharmaceuticals (36E797)

POSTED

about 10 hours ago

DEADLINE

in 12 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS